UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5027-5033

2005

Volltextzugriff (PDF)

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

Nature medicine, 2002-01, Vol.8 (1), p.68-74

2002

Volltextzugriff (PDF)

Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival

Blood, 2006-12, Vol.108 (13), p.4178-4186

2006

Volltextzugriff (PDF)

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

Haematologica (Roma), 2010-08, Vol.95 (8), p.1342-1349

2010

Volltextzugriff (PDF)

Tuning Responses to Polatuzumab Vedotin in B-cell Lymphoma

Cancer discovery, 2024-09, Vol.14 (9), p.1577-1580

2024

Volltextzugriff (PDF)

Determinants of outcomes and advances in CD19‐directed chimeric antigen receptor therapy for B‐cell acute lymphoblastic leukemia

European journal of haematology, 2024-01, Vol.112 (1), p.51-63

2024

Volltextzugriff (PDF)

Altered pathways and targeted therapy in double hit lymphoma

Journal of hematology and oncology, 2022-03, Vol.15 (1), p.26-38, Article 26

2022

Volltextzugriff (PDF)

FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma

Blood, 2006-10, Vol.108 (8), p.2720-2725

2006

Volltextzugriff (PDF)

Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

Journal of clinical oncology, 2006-07, Vol.24 (19), p.3121-3127

2006

Volltextzugriff (PDF)

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

Blood, 2007-04, Vol.109 (7), p.2773-2780

2007

Volltextzugriff (PDF)

Role of Bruton's tyrosine kinase in B cells and malignancies

Molecular cancer, 2018-02, Vol.17 (1), p.57-57, Article 57

2018

Volltextzugriff (PDF)

Lenalidomide for the treatment of B-cell lymphoma

Expert opinion on investigational drugs, 2016-09, Vol.25 (9), p.1103-1116

2016

Volltextzugriff (PDF)

Blinatumomab: a historical perspective

Pharmacology & therapeutics (Oxford), 2012-12, Vol.136 (3), p.334-342

2012

Volltextzugriff (PDF)

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

Blood, 2006-06, Vol.107 (11), p.4207-4213

2006

Volltextzugriff (PDF)

Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target

British journal of haematology, 2021-10, Vol.195 (1), p.113-118

2021

Volltextzugriff (PDF)

Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study

Haematologica (Roma), 2020-09, Vol.105 (9), p.2298-2307

2020

Volltextzugriff (PDF)

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

Cochrane database of systematic reviews, 2007-10, Vol.2010 (4), p.CD003805

2007

Volltextzugriff (PDF)

Multidisciplinary Diagnostic Approach in Intraocular Lymphoma Featuring Pseudo-hypopyon: Case Series and Literature Review

Ocular immunology and inflammation, 2021-04, Vol.29 (3), p.490-495

2021

Volltextzugriff (PDF)

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

Blood, 2019-09, Vol.134 (11), p.851-859

2019

Volltextzugriff (PDF)

Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)

Blood, 2003-06, Vol.101 (11), p.4279-4284

2003

Volltextzugriff (PDF)

Time-to-response for patients with relapsed/refractory diffuse large B cell and high grade B cell lymphoma treated with polatuzumab-based therapy

Leukemia & lymphoma, 2022-01, Vol.63 (1), p.243-246

2022

Volltextzugriff (PDF)

Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?

Journal of clinical oncology, 2022-06, Vol.40 (18), p.2063-2064

2022

Volltextzugriff (PDF)

Gemcitabine enhances rituximab‐mediated complement‐dependent cytotoxicity to B cell lymphoma by CD20 upregulation

Cancer science, 2016-05, Vol.107 (5), p.682-689

2016

Volltextzugriff (PDF)

Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori–positive gastric diffuse large B-cell lymphomas

Blood, 2012-05, Vol.119 (21), p.4838-4844

2012

Volltextzugriff (PDF)

26 – 50 von 15.705

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13.815)
Mit Volltextzugriff
(11.990)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(14.745)
Science & Technology
(12.670)
Life Sciences & Biomedicine
(12.395)
Male
(7.600)
Female
(7.213)
Oncology
(6.020)
Middle Aged
(5.935)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(5.919)
Aged
(5.150)
Hematology
(4.842)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4.805)
Adult
(4.545)
Lymphoma
(3.701)
Biological And Medical Sciences
(3.447)
Medical Sciences
(3.430)
Lymphoma, B-Cell - Drug Therapy
(3.139)
Treatment Outcome
(3.098)
Rituximab
(2.920)
Prognosis
(2.365)
Lymphoma, Large B-Cell, Diffuse - Pathology
(2.352)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(15.204)
EZB Electronic Journals Library
(8.063)
Journals@Ovid Complete
(6.437)
Ingenta.com
(5.395)
NUS Single-Journal Subscriptions
(3.463)
IngentaConnect Journals
(2.653)
Wiley Online Library Journals Frontfile Complete
(2.284)
Wiley Online Library Full Collection 2018
(1.916)
Springer Nature - Complete Springer Journals
(1.766)
ScienceDirect
(1.704)
Taylor & Francis Journals
(1.289)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.220)
Taylor & Francis Current Content Access
(1.218)
Taylor & Francis Online
(1.090)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(949)
Springer Nature - Connect here FIRST to enable access
(758)
Nexis Uni
(732)
SpringerLink Series
(281)
Oxford journals
(275)
BMJ Journals
(257)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(20)
... seit 90 Tagen
(92)

Menü

Weitere Dienste

Einstellungen

Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

Tuning Responses to Polatuzumab Vedotin in B-cell Lymphoma

Determinants of outcomes and advances in CD19‐directed chimeric antigen receptor therapy for B‐cell acute lymphoblastic leukemia

Altered pathways and targeted therapy in double hit lymphoma

FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma

Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

Role of Bruton's tyrosine kinase in B cells and malignancies

Lenalidomide for the treatment of B-cell lymphoma

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study

Blinatumomab: a historical perspective

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target

Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

Multidisciplinary Diagnostic Approach in Intraocular Lymphoma Featuring Pseudo-hypopyon: Case Series and Literature Review

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)

Time-to-response for patients with relapsed/refractory diffuse large B cell and high grade B cell lymphoma treated with polatuzumab-based therapy

Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?

Gemcitabine enhances rituximab‐mediated complement‐dependent cytotoxicity to B cell lymphoma by CD20 upregulation

Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori–positive gastric diffuse large B-cell lymphomas

Suchergebnisse filtern